Clinical Trials · NCT02977897

Fecal Calprotectin Levels in Mycophenolate Mofetil Induced Diarrhea and Treatment With Octreotide

Phase
N/A
Recruitment status
Unknown
Sponsor
University Health Network, Toronto
Enrollment
10
Start date
Jan 2017
Locations
1 site, Canada
Primary endpoint
Measurement of Fecal Calprotectin levels patients with diarrhea on MMF
View Octreotide compound reference